Browse studies

Find your next paid study

27,375 recruiting studies available now

RIsEStroke (Recovery Insights Into Early Mobility Post Stroke)

This study is designed to better understand how patients with severe stroke move during their hospital stay. It will track their activity using a small wearabl…

Acute Ischemic Stroke

Estimated

~$10 – $750

Actual pay is set by the research site.

Wake Forest University Health SciencesNCT07638462

OneRF® Ablation System Post-Market Real-World Evidence Registry

This is a multi-site registry study that aims to collect real-world clinical outcomes and device performance of the OneRF Ablation System. The study focuses on…

Drug Resistant EpilepsyRefractory Epilepsy

Estimated

~$10 – $1,050

Actual pay is set by the research site.

NeuroOne Medical Technologies CorporationNCT07546253

Observational

Food Sequencing in Food Insecurity: The Impact of Food Order/Meal Sequence Counseling Added to Standard Care and a Produce Delivery Program in People With Diabetes/Prediabetes Who Experience Food Insecurity.

The purpose of this study is study the impact of meal sequencing when added to standard care in individuals with diabetes mellitus/prediabetes who receive prod…

PrediabetesDiabetes MellitusFood Insecurity

Estimated

~$10 – $750

Actual pay is set by the research site.

Weill Medical College of Cornell UniversityNCT07488767

Observational

Randomized Controlled Trial of Electronic Clinical Decision Support Systems for Improving Care Management and Clinical Outcomes for Adults With Steatotic Liver Disease

The overall objectives of this study are to determine the effectiveness of a participant-specific guided electronic decision support system on provider decisio…

MASLD

Estimated

~$10 – $750

Actual pay is set by the research site.

Vanderbilt University Medical CenterNCT07382349

Phase 1

A Seamless Phase 1/2 Open-label Study to Evaluate the Safety, Determine the Maximum Tolerated Dose of Administered Activity, and Evaluate the Efficacy of the Therapeutic Radiopharmaceutical [Ac 225]-RTX-2358 in the Treatment of Relapsed or Refractory Sarcoma

The goal of this clinical trial is to learn about the safety of drug \[Ac225\]RTX-2358 and the diagnostic imaging agent \[Cu64\]LNTH-1363S. Additionally Ratio …

Advanced Soft Tissue Sarcoma

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Ratio Therapeutics, Inc.NCT07156565

Phase 3

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy: A Prospective, Single-arm, Multi-center, Blinded-review, Phase 3 Diagnostic Performance Study

The aim for this study is to assess the diagnostic performance of 64Cu-SAR-bisPSMA PET to detect regional nodal metastases.

Prostate CancerProstatic Neoplasms

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Clarity Pharmaceuticals LtdNCT06056830

Phase 1

Repurposing a Combination Antiretroviral Drug Therapy to Target Retrotransposons and Treat Early Alzheimer's Disease

The goal of this clinical trial is to determine the safety, tolerability, drug levels and biological effects of two doses of emtricitabine (FTC) and tenofovir …

Alzheimer's Disease

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Brigham and Women's HospitalNCT07795307

Phase 1

A Pilot/Phase 1 Study of Immunosuppression-free Regulatory T-cell Graft-engineered Haploidentical Hematopoietic Cell Transplantation in Relapsed/Refractory and Ultra-High-risk AML/MDS

This research study is evaluating the safety and efficacy of the IS-free Treg-cell graft-engineered haplo transplant method in people with relapsed/refractory …

Stem Cell Transplant ComplicationsGraft Vs Host DiseaseMyeloid Leukemia, Acute+2 more

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Dana-Farber Cancer InstituteNCT04678401

Observational

Self-Directed Upper Extremity Gaming in Inpatients With Stroke: A Feasibility Study

STRIVE uses a camera mounted on the in-room TV and a connected laptop to track arm and hand movements during gameplay via markerless motion capture. No control…

Stroke

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Milap SandhuNCT07806097

An Observational Long-term Follow-up Study for Patients Previously Treated With Autologous ex Vivo Gene Therapy for Severe Combined Immunodeficiency Due to Adenosine Deaminase Deficiency (ADA-SCID)

This observational long-term follow-up study is designed to collect safety and efficacy data from ADA-SCID patients previously treated with autologous ex vivo …

Adenosine Deaminase DeficiencySevere Combined Immunodeficiency (SCID)

Estimated

Pay not disclosed — ask the coordinator

University of California, Los AngelesNCT04049084

Phase 1

A Phase 1b and 2 Study of Roginolisib (IOA-244) Combined With Obinutuzumab Followed by Venetoclax in Patients With Refractory/Relapsed Chronic Lymphocytic Leukemia (CLL) After Progression on Prior Bruton Tyrosine Kinase (BTK) Inhibitors

This is a Phase 1b and 2, open-label, single-arm study evaluating the safety, tolerability, and efficacy of roginolisib (IOA-244) in combination with obinutuzu…

Chronic Lymphocytic Leukemia (CLL)Refractory Chronic Lymphocytic Leukemia

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Dana-Farber Cancer InstituteNCT07847957

Phase 1

A Pilot Study of Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Bone Marrow or Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies

This research is being done to investigate the safety and effectiveness of Darzalex Faspro (daratumumab and hyaluronidase-fihj) (a monoclonal antibody that tar…

Hematologic MalignancyBone Marrow Transplant RejectionAcute Myeloid Leukemia (AML)+9 more

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins